Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 69
Filtrar
3.
Dermatol Surg ; 46(9): 1204-1209, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-31743246

RESUMEN

BACKGROUND: Chemical peels are applied to the face and neck to improve rhytides and the photoaged appearance of the skin. Peels can be applied to different skin depths depending on the types of chemicals, the volume of solution, and the amount of pressure or friction applied. If a peel is applied too superficially, rhytides will not be removed. If a peel is applied too deeply, scarring or hypopigmentation could occur. OBJECTIVE: To create face and neck depth maps for chemical peeling, which can guide safety when removing rhytides and improving the skin's appearance. MATERIALS AND METHODS: A multicenter retrospective review of records was conducted of patients who underwent phenol-croton oil peeling, from January 1, 2018, to December 31, 2018. Information was collected on facial and neck cosmetic units peeled, peel formula and strength used, outcomes, and complications. RESULTS: A total of 410 patients received deep peels. Two depth maps were created that corresponded to the most common patterns of deep chemical peel applications. CONCLUSION: Different areas of the face and neck are treated with different chemical peel application depths to safely improve rhytides and appearance. Depth maps are created to balance safety and efficacy.


Asunto(s)
Quimioexfoliación/métodos , Dermabrasión/métodos , Queratolíticos/administración & dosificación , Administración Cutánea , Adulto , Anciano , Anciano de 80 o más Años , Quimioexfoliación/efectos adversos , Aceite de Crotón/administración & dosificación , Aceite de Crotón/efectos adversos , Dermabrasión/efectos adversos , Cara/anatomía & histología , Femenino , Humanos , Queratolíticos/efectos adversos , Masculino , Persona de Mediana Edad , Cuello/anatomía & histología , Fenol/administración & dosificación , Fenol/efectos adversos , Estudios Retrospectivos , Piel/anatomía & histología , Piel/efectos de los fármacos , Envejecimiento de la Piel , Resultado del Tratamiento
5.
PLoS One ; 13(7): e0199009, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30059558

RESUMEN

Pain and inflammation are complex clinical conditions that are present in a wide variety of disorders. Most drugs used to treat pain and inflammation have potential side effects, which makes it necessary to search for new sources of bioactive molecules. In this paper, we describe the ability of LASSBio-1586, an N-acylhydrazone derivative, to attenuate nociceptive behavior and the inflammatory response in mice. Antinociceptive activity was evaluated through acetic acid-induced writhing and formalin-induced nociception tests. In these experimental models, LASSBio-1586 significantly (p<0.05) reduced nociceptive behavior. Several methods of acute and chronic inflammation induced by different chemical (carrageenan, histamine, croton oil, arachidonic acid) and physical (cotton pellet) agents were used to evaluate the anti-inflammatory effect of LASSBio-1586. LASSBio-1586 exhibited potent anti-inflammatory activity in all tests (p<0.05). Study of the mechanism of action demonstrated the possible involvement of the nitrergic, serotonergic and histamine signaling pathways. In addition, a molecular docking study was performed, indicating that LASSBio-1586 is able to block the COX-2 enzyme, reducing arachidonic acid metabolism and consequently decreasing the production of prostaglandins, which are important inflammatory mediators. In summary, LASSBio-1586 exhibited relevant antinociceptive and anti-inflammatory potential and acted on several targets, making it a candidate for a new multi-target oral anti-inflammatory drug.


Asunto(s)
Analgésicos/farmacología , Antiinflamatorios no Esteroideos/farmacología , Inhibidores de la Ciclooxigenasa 2/farmacología , Edema/tratamiento farmacológico , Hidrazonas/farmacología , Nocicepción/efectos de los fármacos , Dolor Nociceptivo/tratamiento farmacológico , Ácido Acético , Analgésicos/síntesis química , Animales , Antiinflamatorios no Esteroideos/síntesis química , Ácido Araquidónico/administración & dosificación , Carragenina/administración & dosificación , Aceite de Crotón/administración & dosificación , Ciclooxigenasa 2/química , Ciclooxigenasa 2/metabolismo , Inhibidores de la Ciclooxigenasa 2/síntesis química , Dexametasona/farmacología , Modelos Animales de Enfermedad , Edema/inducido químicamente , Edema/metabolismo , Edema/patología , Formaldehído , Miembro Posterior , Histamina/administración & dosificación , Hidrazonas/síntesis química , Indometacina/farmacología , Inflamación , Masculino , Ratones , Simulación del Acoplamiento Molecular , NG-Nitroarginina Metil Éster/farmacología , Dolor Nociceptivo/inducido químicamente , Dolor Nociceptivo/metabolismo , Dolor Nociceptivo/fisiopatología , Ondansetrón/farmacología , Prostaglandinas/biosíntesis
6.
Facial Plast Surg Clin North Am ; 22(1): 1-23, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24290993

RESUMEN

Edwin Cortez, Fred Fedok, and Devinder Mangat address questions for discussion and debate. Do you agree or disagree, and why, with the following: "The best method to improve moderate to deep rhytids is the croton oil-phenol peel." "There are no problems with cardiotoxicity with croton oil-phenol peels if done appropriately." "Do not do spot testing with chemical peel agents." How do you handle peels in advanced Fitzpatrick skin types III, IV, V? What is the main factor for rate of reepithelialization: (1) depth of peel, (2) depth of laser, (3) depth of dermabrasion? How has your approach to or technique in chemical peels evolved over the past several years?


Asunto(s)
Quimioexfoliación/métodos , Envejecimiento de la Piel , Quimioexfoliación/efectos adversos , Quimioexfoliación/tendencias , Aceite de Crotón/administración & dosificación , Aceite de Crotón/efectos adversos , Fármacos Dermatológicos/administración & dosificación , Fármacos Dermatológicos/efectos adversos , Combinación de Medicamentos , Etanol/administración & dosificación , Etanol/efectos adversos , Humanos , Ácido Láctico/administración & dosificación , Ácido Láctico/efectos adversos , Fenol/administración & dosificación , Fenol/efectos adversos , Repitelización/fisiología , Resorcinoles/administración & dosificación , Resorcinoles/efectos adversos , Salicilatos/administración & dosificación , Salicilatos/efectos adversos , Ácido Tricloroacético/administración & dosificación , Ácido Tricloroacético/efectos adversos
7.
J Pharmacol Toxicol Methods ; 69(2): 189-95, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24333504

RESUMEN

INTRODUCTION: Currently, there is a paucity of scientific literature and reports related to screening models for non-infectious type of pharyngitis. In this context, we made a sincere attempt to establish a novel animal model for screening drugs against non-infectious pharyngitis in rats. We have considered the use of pyridine, croton oil and their combination for inducing non-infectious pharyngitis in rats. METHODS: Various concentrations of pyridine were applied topically to the pharyngeal region of rats and the extent of inflammation was assessed by Evans Blue (EB) dye exudation test, evaluating the serum levels of proinflammatory cytokines and histopathology. Dexamethasone and diclofenac were used as reference standards. RESULTS: Upon pyridine application (2.5%, 5%, 10%, 20%, 40% and 80% in saline), dose-dependent increase in EB dye extravasation was observed (increased vascular permeability). In addition, the levels of TNF-α (P<0.01) and IL-6 (P<0.01) were significantly increased compared to control. Furthermore, the histopathology of pharyngeal tissue showed hypertrophy of submucosal glands, severe inflammation of the pharynx characterised by presence of mononuclear cells, neutrophils along with haemorrhages and congestion; however, normal control animals showed normal cytoarchitecture of pharynx. Indeed, dexamethasone (0.25, 0.5 and 1 mg/kg, i.v.) and diclofenac (1, 2.5 and 5 mg/kg, i.v.) showed dose-dependent protection against pyridine-induced pharyngitis. Further, the possible mechanism of pyridine-induced pharyngitis is thought to be primarily mediated through phospholipase A2 and cyclooxygenase (COX) pathway. CONCLUSION: These findings suggest that pyridine-induced pharyngitis is a simple and versatile novel animal model for screening the drugs against non-infectious pharyngitis in rats.


Asunto(s)
Aceite de Crotón/administración & dosificación , Modelos Animales de Enfermedad , Faringitis/inducido químicamente , Piridinas/administración & dosificación , Animales , Relación Dosis-Respuesta a Droga , Faringitis/patología , Ratas , Ratas Wistar
8.
Plast Reconstr Surg ; 132(5): 743e-753e, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24165626

RESUMEN

BACKGROUND: Face-lift surgery when combined with perioral phenol-croton oil peel is an underappreciated tool for face rejuvenation. The procedure results in significant central face skin tightening and wrinkle reduction. METHODS: A retrospective review of 47 consecutive patients who underwent simultaneous face lift and perioral peel was performed. The objective measures used to evaluate the change in appearance of the patients included (1) a validated patient satisfaction questionnaire, (2) an evaluation of apparent age, and (3) an evaluation of perioral wrinkles by independent reviewers using a validated model. The assessment of apparent age was performed as follows: preoperative and postoperative photographs were shown randomly to six reviewers, who were asked to estimate the patient's age. The apparent age was compared with the patient's actual age, and the reduction in apparent age was calculated. Improvement in perioral rhytides was evaluated by using the Glogau classification system (range, 1 to 4). RESULTS: Survey results documented overall patient satisfaction, which was rated as 6.5 on a scale of 1 to 7 (with higher scores indicating greater satisfaction). Patients' postoperative apparent age estimate was 8.2 years younger than their real age (p=0.0002). The Glogau classification system score demonstrated a mean reduction of 1.15 (3.3 preoperatively as compared with 2.15 postoperatively, p<0.0001). CONCLUSION: Outcomes measurements, including patient satisfaction, objective evaluation of wrinkle improvement, and significant reduction in apparent age, document the power of this technique. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.


Asunto(s)
Quimioexfoliación/métodos , Aceite de Crotón/administración & dosificación , Fenol/administración & dosificación , Ritidoplastia , Envejecimiento de la Piel , Anciano , Femenino , Humanos , Persona de Mediana Edad , Estudios Retrospectivos , Envejecimiento de la Piel/efectos de los fármacos , Resultado del Tratamiento
9.
ScientificWorldJournal ; 2013: 376216, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24379740

RESUMEN

OBJECTIVE: To optimize the conditions for the extraction of alkaloid palmatine from Tinospora cordifolia by using response surface methodology (RSM) and study its anticancerous property against 7,12-dimethylbenz(a)anthracene (DMBA) induced skin carcinogenesis in Swiss albino mice. METHODS: The effect of three independent variables, namely, extraction temperature, time, and cycles was investigated by using central composite design. A single topical application of DMBA (100 µg/100 µL of acetone), followed 2 weeks later by repeated application of croton oil (1% in acetone three times a week) for 16 weeks, exhibited 100 percent tumor incidence (Group 2). RESULTS: The highest yield of alkaloid from Tinospora cordifolia could be achieved at 16 hours of extraction time under 40°C with 4 extraction cycles. Alkaloid administration significantly decreases tumor size, number, and the activity of serum enzyme when compared with the control (Group 2). In addition, depleted levels of reduced glutathione (GSH), superoxide dismutase (SOD), and catalase and increased DNA damage were restored in palmatine treated groups. CONCLUSION: The data of the present study clearly indicate the anticancer potential of palmatine alkaloid in DMBA induced skin cancer model in mice.


Asunto(s)
Antineoplásicos/farmacología , Alcaloides de Berberina/farmacología , Extractos Vegetales/farmacología , Tinospora/química , 9,10-Dimetil-1,2-benzantraceno/administración & dosificación , 9,10-Dimetil-1,2-benzantraceno/efectos adversos , Alanina Transaminasa/sangre , Animales , Antineoplásicos/administración & dosificación , Aspartato Aminotransferasas/sangre , Alcaloides de Berberina/administración & dosificación , Carcinógenos/administración & dosificación , Catalasa/metabolismo , Transformación Celular Neoplásica/inducido químicamente , Quimioprevención , Aceite de Crotón/administración & dosificación , Aceite de Crotón/efectos adversos , Daño del ADN/efectos de los fármacos , Modelos Animales de Enfermedad , Glutatión/metabolismo , Ratones , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/administración & dosificación , Extractos Vegetales/química , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/prevención & control , Superóxido Dismutasa/metabolismo
10.
Asian Pac J Cancer Prev ; 11(2): 371-5, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20843118

RESUMEN

The aim of the study was to examine whether Momordica fruit extract (MFE) and Momordica leaves extract (MLE) might exert any chemopreventive effect in a two stage protocol in skin carcinogenesis with Swiss albino mice. The tumour incidence, tumour yield, tumour burden and cumulative no. of papillomas were found to be higher in the controls (without either extract) as compared to the MFE or MLE treated experimental groups. In a melanoma model, the mice which received fruit and leaf extracts of Momordica at the doses of 500 and 1000 mg/kg body weight for 30 days showed increase in life span of animals and tumour volume was significantly reduced as compared to control values. In cytogenetic studies, a single application of Momordica extracts at doses of 500, 1000 and 1500 mg/kg body weight, 24 hours prior the i.p. administration of cyclophosphamide, significantly prevented micronucleus formation and chromosomal aberrations in a dose dependent manner in bone marrow cells of mice. The present study demonstrate chemopreventive potential of Momordica fruit and leaf extracts on DMBA induced skin tumorigenesis, melanoma tumour and cytogenicity.


Asunto(s)
Antineoplásicos/uso terapéutico , Melanoma Experimental/prevención & control , Momordica charantia/efectos de los fármacos , Papiloma/prevención & control , Fitoterapia , Extractos Vegetales/uso terapéutico , Neoplasias Cutáneas/prevención & control , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Animales , Células de la Médula Ósea/efectos de los fármacos , Células de la Médula Ósea/patología , Carcinógenos/toxicidad , Aberraciones Cromosómicas , Aceite de Crotón/administración & dosificación , Femenino , Frutas/efectos de los fármacos , Masculino , Melanoma Experimental/genética , Melanoma Experimental/patología , Ratones , Ratones Endogámicos C57BL , Papiloma/inducido químicamente , Papiloma/patología , Hojas de la Planta/efectos de los fármacos , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/patología , Tasa de Supervivencia
11.
Asian Pac J Cancer Prev ; 11(1): 261-5, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20593968

RESUMEN

Syzygium cumini L. is widely used for the treatment of diabetes in various parts of India. The protective efficacy of S. cumini seed extract (SCE) against peroxidative damage contributing to skin carcinogenesis in Swiss albino mice was tested in the present study. A single topical application of 7,12-dimethyl benz(a)anthracene (100 microg/100 microl acetone), followed 2 weeks later by repeated application of croton oil (1% in acetone three times a week) and continued till the end of the experiment (i.e., 16 weeks) caused a 100% tumor incidence. In contrast, mice treated with the SCE (125 mg/ kg/ b.wt./ animal /day) in either the peri (i.e. 7 days before and 7 days after the application of DMBA) or post-initiation (i.e. from the day of start of croton oil treatment and continued till the end of the experiment) phases demonstrated significant reduction in cumulative numbers of papillomas and tumor incidence (75%). The average latency period in the SCE treated group was also significantly increased (Pre Group - 11.1 weeks; Post Group - 10.9 weeks) as compared with the carcinogen control group (7.9). Results from the present study indicate that the anticarcinogenic activity of SCE during DMBA-induced skin papillomagenesis is mediated through alteration of antioxidant status. Thus, SCE can be considered as a readily accessible, promising novel cancer chemopreventive agent.


Asunto(s)
9,10-Dimetil-1,2-benzantraceno/toxicidad , Carcinógenos/toxicidad , Papiloma/prevención & control , Fitoterapia , Extractos Vegetales/uso terapéutico , Neoplasias Cutáneas/prevención & control , Syzygium/química , Animales , Aceite de Crotón/administración & dosificación , Modelos Animales de Enfermedad , Masculino , Ratones , Papiloma/inducido químicamente , Papiloma/patología , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/patología
12.
Aesthet Surg J ; 28(1): 33-45, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19083504

RESUMEN

This author discusses the utility and versatility of the modern croton oil peel, which, unlike older formulations, may be used for all ages and skin types for effective and long-lasting skin resurfacing. He provides the rationale for various croton oil concentrations, focusing on avoiding complications while achieving a desirable clinical result and includes a comprehensive guide to application, appropriate formulas, and the perioperative process. Of significance is that this is a procedure with a distinct learning curve; the goal for the experienced practitioner is to control the application process, proceeding slowly enough to be able to stop at the appropriate depth.


Asunto(s)
Quimioexfoliación/métodos , Aceite de Crotón/administración & dosificación , Fármacos Dermatológicos/administración & dosificación , Complicaciones Posoperatorias/prevención & control , Envejecimiento de la Piel/efectos de los fármacos , Quimioexfoliación/efectos adversos , Aceite de Crotón/uso terapéutico , Fármacos Dermatológicos/uso terapéutico , Esquema de Medicación , Composición de Medicamentos/métodos , Femenino , Humanos , Persona de Mediana Edad , Educación del Paciente como Asunto , Atención Perioperativa/métodos , Retratamiento/métodos , Factores de Riesgo , Cicatrización de Heridas
13.
Biol Pharm Bull ; 29(11): 2241-5, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17077521

RESUMEN

The present study evaluated the effect of the crude extract of the leaves of Nectandra falcifolia (NEES) Castiglioni and its fractions in different experimental models of inflammation (paw edema, pleurisy, and ear edema). Carrageenan-induced edema of the paw and pleurisy were evaluated in Wistar rats (180-220 g), which were treated with different doses of the total extract (250, 500 mg.kg-1). Edema of the ear, induced by croton oil, and determination of myeloperoxidase activity were evaluated in Swiss mice (25-35 g). In this experiment, the crude extract of Nectandra falcifolia (Nf) (1.25, 2.5, 5.0, 7.5 mg) and the hexane, chloroform, ethyl-acetate and hydromethanol fractions (5.0 mg) were applied topically, immediately after application of the oil. The crude extract of Nf (500 mg.kg-1) significantly reduced edema of the paw compared to the control group. Similarly, at doses of 250 and 500 mg.kg-1 it significantly reduced the volume of pleural inflammatory exudate compared to the control animals. However, it did not change the number of migrated cells. At doses of 2.5, 5.0 and 7.5 mg, the crude extract significantly inhibited edema of the ear and the influx of neutrophils. The fractions from Nectandra falcifolia (hexane, chloroform, ethyl acetate and hydromethanol) also inhibited edema of the ear. Taken together, the results demonstrated that the crude extract and its fractions administered to animals orally or topically showed an anti-inflammatory effect.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Lauraceae/química , Extractos Vegetales/uso terapéutico , Hojas de la Planta/química , Administración Oral , Animales , Antiinflamatorios no Esteroideos/química , Antiinflamatorios no Esteroideos/farmacología , Carragenina/administración & dosificación , Carragenina/toxicidad , Aceite de Crotón/administración & dosificación , Aceite de Crotón/toxicidad , Evaluación Preclínica de Medicamentos/métodos , Oído/patología , Edema/inducido químicamente , Edema/metabolismo , Edema/prevención & control , Miembro Posterior/efectos de los fármacos , Miembro Posterior/patología , Indometacina/farmacología , Indometacina/uso terapéutico , Inflamación/inducido químicamente , Inflamación/metabolismo , Inflamación/prevención & control , Inyecciones Intradérmicas , Masculino , Óxido Nítrico/metabolismo , Peroxidasa/metabolismo , Fitoterapia/métodos , Extractos Vegetales/química , Extractos Vegetales/farmacología , Pleuresia/inducido químicamente , Pleuresia/metabolismo , Pleuresia/prevención & control , Ratas , Ratas Wistar , Solventes/química
14.
Phytother Res ; 20(11): 981-6, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16927448

RESUMEN

The chemopreventive potential of rosemary (Rosmarinus officinalis) on 7,12-dimethlybenz(a)anthracene (DMBA) initiated and croton oil promoted mouse skin tumorigenesis was assessed. The modulatory effects of R. officinalis was monitored on the basis of the average latency period, tumor incidence, tumor burden, tumor yield, tumor weight and diameter as well as lipid peroxidation and glutathione level. The results indicate that R. officinalis leaves extract could prolong the latency period of tumor occurrence, decrease the tumor incidence, tumor burden and tumor yield. The average weight and diameter of tumors recorded were comparatively lower in the rosemary extract treated mouse groups. The level of lipid peroxidation was significantly reduced in blood serum and liver. Furthermore, depleted levels of glutathione were restored in RE-administered animal groups. Thus, at a dose rate of 500 mg/kg body wt/mouse, the oral administration of rosemary extract was found to be significantly protective against two-stage skin tumorigenesis.


Asunto(s)
Fitoterapia , Extractos Vegetales/farmacología , Rosmarinus/química , Neoplasias Cutáneas/tratamiento farmacológico , Carga Tumoral/efectos de los fármacos , 9,10-Dimetil-1,2-benzantraceno/administración & dosificación , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Animales , Aceite de Crotón/administración & dosificación , Glutatión/análisis , Glutatión/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Hígado/química , Hígado/efectos de los fármacos , Masculino , Ratones , Extractos Vegetales/administración & dosificación , Hojas de la Planta/química , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/patología
15.
Clin Exp Pharmacol Physiol ; 33(3): 238-47, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16487268

RESUMEN

The essential oil of Croton zehntneri Pax et Hoffm. (EOCZ) contains anethole (42%) and estragole (46%), two isomers that share some chemical structural similarities with capsaicin. The present study investigated the cardiovascular effects of EOCZ and the role of capsaicin-sensitive sensory nerve fibres in the mediation of these effects in anaesthetized rats. 2. Intravenous bolus injection of EOCZ (1-20 mg/kg) elicited dose-dependent hypotension and bradycardia that were immediate and transient. Similar responses were also observed with anethole and estragole (both at 10 mg/kg). After cervical bivagotomy or perineural treatment of both cervical vagus nerves with capsaicin (250 mg/mL) to selectively block the conduction of sensory C-fibres, both cardiovascular responses to EOCZ (10 mg/kg) were abolished. 3. Like capsaicin, an epigastric retrograde intra-arterial injection of EOCZ (10 mg/kg, i.a.) into the femoral artery elicited a monophasic hypotensive response. This reflex response was blocked by either neonatal pretreatment with capsaicin (50 mg/kg, s.c.) or intrathecal injection of the substance P receptor antagonist RP 67580 (7.8 nmol, at the spinal level L5-L6), suggesting that it is mediated exclusively by substance P-containing primary afferent fibres. 4. The cardiovascular responses to EOCZ (10 mg/kg, i.v.) were also significantly reduced by the selective vallinoid TPRV1 receptor antagonist capsazepine (1 mg/kg, i.v.). 5. It is concluded that i.v. administration of EOCZ in anaesthetized rats elicits a capsaicin-like bradycardic and depressor reflex, which appears to be mediated by the activation of vallinoid TPRV1 receptors located on vagal sensory nerves. Like capsaicin, i.a. injection of EOCZ induces a spinally mediated sensory reflex.


Asunto(s)
Capsaicina/farmacología , Sistema Cardiovascular/efectos de los fármacos , Aceite de Crotón/farmacología , Croton/química , Neuronas Aferentes/efectos de los fármacos , Derivados de Alilbenceno , Anestesia , Animales , Animales Recién Nacidos , Anisoles/administración & dosificación , Anisoles/farmacología , Presión Sanguínea/efectos de los fármacos , Aceite de Crotón/administración & dosificación , Relación Dosis-Respuesta a Droga , Arteria Femoral , Frecuencia Cardíaca/efectos de los fármacos , Hemodinámica/efectos de los fármacos , Inyecciones Intraarteriales , Masculino , Fibras Nerviosas Amielínicas/efectos de los fármacos , Hojas de la Planta/química , Ratas , Ratas Wistar , Canales Catiónicos TRPV/efectos de los fármacos
16.
Eur J Pharmacol ; 530(1-2): 166-71, 2006 Jan 13.
Artículo en Inglés | MEDLINE | ID: mdl-16375889

RESUMEN

One of the major factors limiting the use of non-steroidal anti-inflammatory drugs is gastrointestinal toxicity. Gaultherin, 2-[(6-O-beta-D-Xylopyranosyl-beta-D-glucopyranosyl)oxy] benzoic acid methyl ester, a natural salicylate derivative extracted from Gaultheria yunnanensis, has been shown to have analgesic and anti-inflammatory effects and lack gastric ulcerogenic effect compared to aspirin in our primary study. The aim of this study was to investigate the mechanism of action of gaultherin, which may rely on its active metabolite, and the mechanism responsible for the non-ulcerogenic property. The results showed that gaultherin (200 mg/kg) significantly inhibited the abdominal contractions in the acetic acid-induced writhing test in mice. The anti-inflammatory effect of gaultherin was demonstrated in the croton oil-induced ear edema model in mice. The results showed that gaultherin and equimolar dose of aspirin produced comparable inhibitory effects. The study of the metabolism characters of gaultherin in mice and rats indicated that gaultherin could be metabolically converted to salicylate, which produced the pharmacological effects, and provided effective concentrations for an extended period. In vitro metabolism experiment showed that gaultherin was metabolized by beta-glycosidase produced by human intestinal bacteria and esterases in intestine, blood and liver successively to release salicylate finally. The study suggested gaultherin did not cause gastric ulcer for the reason that it released salicylate in intestine slowly, not in stomach and it left the cyclooxygenase-1 unaffected, which was the source of cytoprotective prostaglandins in gastric epithelium.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Disacáridos/farmacología , Gaultheria/química , Salicilatos/farmacología , Dolor Abdominal/inducido químicamente , Dolor Abdominal/tratamiento farmacológico , Ácido Acético/administración & dosificación , Ácido Acético/toxicidad , Administración Oral , Animales , Antiinflamatorios no Esteroideos/aislamiento & purificación , Aspirina/administración & dosificación , Aspirina/toxicidad , Cromatografía Líquida de Alta Presión , Aceite de Crotón/administración & dosificación , Aceite de Crotón/toxicidad , Disacáridos/metabolismo , Modelos Animales de Enfermedad , Enfermedades del Oído/inducido químicamente , Enfermedades del Oído/tratamiento farmacológico , Esterasas/metabolismo , Mucosa Gástrica/química , Mucosa Gástrica/efectos de los fármacos , Mucosa Gástrica/patología , Glicósido Hidrolasas/metabolismo , Humanos , Inmersión , Inflamación/inducido químicamente , Inflamación/tratamiento farmacológico , Intestinos/efectos de los fármacos , Intestinos/microbiología , Masculino , Ratones , Hojas de la Planta/química , Tallos de la Planta/química , Ratas , Ratas Wistar , Restricción Física , Salicilatos/química , Salicilatos/metabolismo , Úlcera Gástrica/etiología , Úlcera Gástrica/patología , Estrés Psicológico/complicaciones , Agua
17.
J Immunol ; 173(10): 6403-8, 2004 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-15528380

RESUMEN

PECAM is a molecule used specifically during the diapedesis step when neutrophils and monocytes leave the blood compartment. Anti-PECAM reagents, such as Abs and soluble fusion proteins, block diapedesis both in vivo and in vitro. However, the PECAM knockout mouse in C57BL/6 strain has no serious defects in most models of inflammation. We show in this study that the same PECAM knockout backcrossed into the FVB/n strain clearly has reduced leukocyte emigration in two models of inflammation. Furthermore, we show that anti-PECAM reagents can block leukocyte emigration in several other wild-type strains of mice like FVB/n, SJL, and the outbred strain Swiss Webster. This clearly shows that the C57BL/6 strain is uniquely able to compensate for the loss of PECAM function. Murine models of inflammatory disease that have been studied using C57BL/6 mice should be re-evaluated using FVB/n or other mouse strains to determine whether PECAM plays a role in those models.


Asunto(s)
Inhibición de Migración Celular , Movimiento Celular/genética , Movimiento Celular/inmunología , Regulación hacia Abajo/inmunología , Leucocitos/inmunología , Leucocitos/metabolismo , Molécula-1 de Adhesión Celular Endotelial de Plaqueta/genética , Molécula-1 de Adhesión Celular Endotelial de Plaqueta/inmunología , Animales , Anticuerpos Bloqueadores/farmacología , Cruzamientos Genéticos , Aceite de Crotón/administración & dosificación , Dermatitis por Contacto/genética , Dermatitis por Contacto/inmunología , Dermatitis por Contacto/patología , Modelos Animales de Enfermedad , Regulación hacia Abajo/genética , Silenciador del Gen , Leucocitos/patología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Peritonitis/genética , Peritonitis/inmunología , Peritonitis/patología , Molécula-1 de Adhesión Celular Endotelial de Plaqueta/biosíntesis , Especificidad de la Especie , Tioglicolatos/administración & dosificación
18.
Eur J Cancer Prev ; 13(5): 411-7, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15452454

RESUMEN

Selenium, an essential micronutrient, is associated with antioxidant functions, physiological defence mechanisms against different diseases including several types of cancers. Search for new selenium compounds with more chemopreventive activities and lesser toxicities are in progress. In the present study, the antioxidative roles of a synthetic organoselenium compound, diphenylmethyl selenocyanate, were evaluated against 7,12-dimethylbenz(a)anthracene (DMBA)/croton oil-induced two-stage mouse skin carcinogenesis model. The compound was administered orally in carcinogen-induced mice in two different non-toxic doses: 2 mg/kg body weight and 3 mg/kg body weight. Significant inhibition in the incidence of papilloma formation (58-80%) as well as in the cumulative number of papilloma per papilloma-bearing mouse were observed in the treated groups as compared with the carcinogen control group. The compound was also found to significantly upregulate different phase II detoxifying enzymes in liver cytosol such as glutathione-S-transferase (P<0.01), catalase (P<0.01) and superoxide dismutase (SOD) (P<0.01) when measured after 15 days and also after 12 weeks of first DMBA treatment. Lipid peroxidation measured as the thiobarbituric acid reactive substances in liver microsomes was significantly inhibited (P<0.05) in a dose-dependent manner by diphenylmethyl selenocyanate. Thus the compound exerts its chemopreventive activity by reducing papilloma formation during chemically induced carcinogenesis, which in turn, may be through modulating the level of lipid peroxidation and phase II detoxifying enzyme system at the doses evaluated.


Asunto(s)
Anticarcinógenos/farmacología , Compuestos de Organoselenio/farmacología , Papiloma/prevención & control , Neoplasias Cutáneas/prevención & control , 9,10-Dimetil-1,2-benzantraceno/administración & dosificación , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Administración Oral , Animales , Antioxidantes/farmacología , Carcinógenos/administración & dosificación , Carcinógenos/toxicidad , Aceite de Crotón/administración & dosificación , Aceite de Crotón/toxicidad , Fármacos Dermatológicos/administración & dosificación , Fármacos Dermatológicos/toxicidad , Femenino , Peroxidación de Lípido , Ratones , Papiloma/inducido químicamente , Neoplasias Cutáneas/inducido químicamente
20.
Indian J Exp Biol ; 41(11): 1325-8, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15332506

RESUMEN

The inhibition of tumor incidence by hydro-alcoholic extract of the whole plant of P. urinaria was evaluated in 6-7 weeks old female albino mice on two-stage process of skin carcinogenesis induced by a single application of 7,12-dimethylbenz(a)anthracene (50 microg/50 microl of acetone), and 2 weeks later, promoted by repeated application of croton oil (1% in acetone/three times a week) till the end of the experiment (15 weeks). Topical application of the extract at a dose of 5 mg/kg body weight/day for 15 weeks at the peri-initiational stage (i.e., 7 days before and 7 days after DMBA application), promotional stage (i.e., from the time of croton oil application) and both peri and post-initiational stages (i.e., 7 days prior to DMBA application and continued till the end of the experiment) on the shaven backs of the mice recorded a significant reduction in tumor incidence to 50, 33.3 and 16.7% respectively in comparison to the control (i.e., the mice treated with DMBA and croton oil only) where tumor incidence was found to be 81.8%. The average number of papillomas per mouse was also significantly reduced. The results suggest a possible chemopreventive property of P. urinaria against DMBA-induced skin papillomagenesis in mice.


Asunto(s)
9,10-Dimetil-1,2-benzantraceno/toxicidad , Phyllanthus/química , Fitoterapia , Extractos Vegetales/uso terapéutico , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/prevención & control , Animales , Carcinógenos/toxicidad , Quimioprevención , Aceite de Crotón/administración & dosificación , Femenino , Ratones , Papiloma/inducido químicamente , Papiloma/patología , Papiloma/prevención & control , Extractos Vegetales/aislamiento & purificación , Neoplasias Cutáneas/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...